Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders

Details for Australian Patent Application No. 2010314844 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Movalia, Mayur; Illingworth, Andrea; Faas Mcknight, Susan; Rother, Russell P.

Agent Shelston IP

Pub. Number AU-A-2010314844

PCT Pub. Number WO2011/057250

Priority 61/280,897 09.11.09 US

Filing date 9 November 2010

Wipo publication date 12 May 2011

International Classifications

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/057250 Priority application(s): WO2011/057250

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010314852-Orthorectifying stitched oblique imagery to a nadir view, and applications thereof

2010314842-Methods of propagating monkey adenoviral vectors